Rex Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.75 Cr
as on 15-11-2024
- Paid Up Capital ₹ 1.50 Cr
as on 15-11-2024
- Company Age 29 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 Cr
as on 15-11-2024
- Satisfied Charges ₹ 10.19 Cr
as on 15-11-2024
- Revenue 10.06%
(FY 2023)
- Profit -59.23%
(FY 2023)
- Ebitda 100.15%
(FY 2023)
- Net Worth -1.66%
(FY 2023)
- Total Assets 17.94%
(FY 2023)
About Rex Remedies
The Corporate was formerly known as Rex Remedies Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.75 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹4.00 Cr. The company has closed loans amounting to ₹10.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shamshad Ahmed, Mohd Arif, Muneef Usmani, and Nine other members serve as directors at the Company.
- CIN/LLPIN
U74899DL1995PLC064991
- Company No.
064991
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Feb 1995
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rex Remedies Limited offer?
Rex Remedies Limited offers a wide range of products and services, including Ayurvedic Medicine, Unani Medicines, Fresh, Dried & Preserved Fruits, Fresh Fruits, Child and Baby Care Products, Baby Care Products, Antibacterial Drugs, Ayurvedic,Herbal Products & Medicine, Cosmetics, Hair & Beauty Products, Hair Care Products.
Who are the key members and board of directors at Rex Remedies?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shamshad Ahmed  | Managing Director | 02-Feb-1995 | Current |
| Mohd Arif | Managing Director | 02-Feb-1995 | Current |
| Muneef Usmani | Managing Director | 17-Jan-2005 | Current |
Board Members(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Monis Akhtar | Director | 27-Jan-2022 | Current |
| Hakeem Halim | Whole-Time Director | 02-Feb-1995 | Current |
| Mohd Asim | Director | 27-Jan-2022 | Current |
| Mohammad Arif | Director | 27-Jan-2022 | Current |
| Mohd Anas | Director | 27-Jan-2022 | Current |
| Aarifa | Director | 27-Jan-2022 | Current |
Financial Performance of Rex Remedies.
Rex Remedies Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.06% increase. The company also saw a substantial fall in profitability, with a 59.23% decrease in profit. The company's net worth dipped by a decrease of 1.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rex Remedies?
In 2023, Rex Remedies had a promoter holding of 58.87% and a public holding of 41.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Especia Foods Private LimitedActive 10 years 6 monthsShamshad Ahmed, Mohd Asim and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 04 Nov 2023 | ₹4.00 M | Open |
Hdfc Bank Limited Creation Date: 22 Apr 2022 | ₹4.00 M | Open |
Hdfc Bank Limited Creation Date: 06 Apr 2022 | ₹4.00 M | Open |
How Many Employees Work at Rex Remedies?
Unlock and access historical data on people associated with Rex Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rex Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rex Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
